Accelerating Australia’s RNA Innovation Pipeline – Southern RNA and UQ BASE
From Bench to Bedside
End-to-End mRNA Capability in Queensland. Transforming Discovery into Clinical Reality.
Southern RNA and The BASE Facility at The University of Queensland have established a collaborative framework that bridges academic research and clinical translation. Together, we provide a clear and efficient pathway for mRNA therapeutics & vaccines, from early construct design and optimisation to GMP-compliant
manufacturing, fully within Australia.
A Seamless Translational Partnership
This collaboration enables researchers to:
- Optimise mRNA constructs at BASE, using processes aligned with Southern RNA’s industry standards.
- Transition efficiently into Southern RNA’s GMP manufacturing platform for clinical development.
- Reduce time and cost associated with technology transfer.
- Ensure continuity of quality, data, and documentation from R&D to clinical production.
See the PDF document here for the full article.
